PT - JOURNAL ARTICLE AU - H Hambley AU - J F Davidson AU - I D Walker AU - M Small AU - C R Prentice TI - Freeze dried cryoprecipitate: a clinical evaluation. AID - 10.1136/jcp.36.5.574 DP - 1983 May 01 TA - Journal of Clinical Pathology PG - 574--576 VI - 36 IP - 5 4099 - http://jcp.bmj.com/content/36/5/574.short 4100 - http://jcp.bmj.com/content/36/5/574.full SO - J Clin Pathol1983 May 01; 36 AB - Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.